UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,833,193
- Total 13F shares
- 41,578,250
- Share change
- +754,770
- Total reported value
- $20,237,803,944
- Put/Call ratio
- 91%
- Price per share
- $487.25
- Number of holders
- 825
- Value change
- +$453,058,249
- Number of buys
- 433
- Number of sells
- 312
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
12%
|
5,352,996
|
$2,244,029,549 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
4,418,610
|
$1,852,325,498 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
5.7%
|
2,441,492
|
$1,189,616,977 | +$202,245,781 | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5.1%
|
2,173,392
|
$911,107,660 | — | 30 Sep 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.7%
|
2,022,222
|
$847,735,685 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.9%
from 13D/G
|
1,922,609
|
$805,976,919 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
1,249,660
|
$522,908,608 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
986,478
|
$413,541,523 | — | 30 Sep 2025 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
1.7%
|
748,550
|
$317,617,251 | — | 30 Sep 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.6%
|
686,710
|
$287,876,000 | — | 30 Sep 2025 | |
| ASSETMARK, INC |
13F
|
Company |
1.5%
|
645,908
|
$270,771,197 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.5%
|
637,223
|
$267,130,253 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
1.3%
|
551,470
|
$231,181,739 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
512,816
|
$214,994,809 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.1%
|
454,718
|
$190,569,761 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
447,018
|
$187,394,415 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
438,804
|
$183,951,887 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.99%
|
425,993
|
$178,580,526 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.82%
|
351,455
|
$147,333,387 | — | 30 Sep 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.79%
|
339,071
|
$142,141,954 | — | 30 Sep 2025 | |
| Swedbank AB |
13F
|
Company |
0.77%
|
329,118
|
$137,969,558 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.75%
|
321,495
|
$134,870,472 | — | 30 Sep 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.74%
|
315,305
|
$132,178,929 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
312,948
|
$131,190,931 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.7%
|
300,931
|
$126,154,000 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.7%
|
300,495
|
$125,970,421 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.67%
|
287,067
|
$120,341,358 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.64%
|
273,982
|
$114,855,994 | — | 30 Sep 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.63%
|
269,072
|
$112,798,000 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.6%
|
258,577
|
$108,398,064 | — | 30 Sep 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.59%
|
253,220
|
$106,152,356 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.58%
|
250,331
|
$104,941,277 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.58%
|
247,937
|
$103,937,669 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.49%
|
208,535
|
$87,419,957 | — | 30 Sep 2025 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.48%
|
205,782
|
$86,265,873 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.47%
|
203,193
|
$85,180,539 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.47%
|
199,656
|
$83,697,791 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
192,844
|
$80,842,134 | — | 30 Sep 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.45%
|
190,626
|
$79,912,325 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.42%
|
180,402
|
$75,626,322 | — | 30 Sep 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.41%
|
176,787
|
$74,111,000 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.41%
|
176,531
|
$74,003,561 | — | 30 Sep 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.41%
|
173,948
|
$72,920,787 | — | 30 Sep 2025 | |
| COMERICA BANK |
13F
|
Company |
0.37%
|
157,952
|
$66,215,014 | — | 30 Sep 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.37%
|
156,367
|
$65,584,470 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
155,404
|
$65,146,911 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.35%
|
150,000
|
$62,881,500 | — | 30 Sep 2025 | |
| SEIZERT CAPITAL PARTNERS, LLC |
13F
|
Company |
0.34%
|
146,991
|
$61,620,097 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.34%
|
146,898
|
$61,581,111 | — | 30 Sep 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.34%
|
146,663
|
$61,482,596 | — | 30 Sep 2025 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2025
As of 31 Dec 2025,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
825 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,578,250 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and ASSETMARK, INC.
This page lists
825
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
701
Q4 2025 holders
825
Holder diff
124
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.